NCT07087873 - Assessment of Transcranial Alternating Current Stimulation's Clinical Efficacy in Treating Cognitive Impairment of Idiopathic Inflammatory Demyelinating Diseases | Biotech Hunter

Enrollment

128

Participants

Timeline

Start Date

May 30, 2025

Primary Completion Date

October 31, 2027

Study Completion Date

October 31, 2027

Conditions

Idiopathic Inflammatory Demyelinating Disorders of the Central Nervous SystemMS (Multiple Sclerosis)NMOSDAcute Disseminated EncephalomyelitisTranscranial Alternating Current Stimulation

Interventions

DEVICE

Neuroelectrical modulation group

Participants received transcranial electrical stimulation using the Spanish Neuroelectrics StarStim 32 device.

DEVICE

Pseudo-neuromodulation group

Pseudo-stimulation is performed using the same equipment and procedures as in the neuromodulation group.

Trial Locations (1)

100053

RECRUITING

Xuanwu Hospital, Capital Medical University, Beijing

All Listed Sponsors

lead

Xuanwu Hospital, Beijing

OTHER